BenevolentAI achieves second major collaboration milestone with novel idiopathic pulmonary fibrosis target selected for AstraZeneca’s portfolio

– Novel target for idiopathic pulmonary fibrosis was discovered using BenevolentAI’s AI-drug discovery platform and experimentally validated by AstraZeneca – Announcement represents the second collaboration milestone following the addition of a novel chronic kidney disease target to AstraZeneca’s portfolio in Q1 2021 BenevolentAI, a leading clinical-stage AI drug discovery company, announced that AstraZeneca has added…

thaipr.net

15 ธ.ค. 64

SET, Walk Free and FAST provide Thai businesses with tools to manage modern slavery risks

The Stock Exchange of Thailand (SET) has partnered with Walk Free and Finance Against Slavery and Trafficking (FAST), two international organizations with business and human rights expertise, to produce a set of tools to manage human rights risks, specifically modern slavery and labor exploitation. The toolkit, which consists of the “Guidance on Modern Slavery Risks […]

thaipr.net

15 ธ.ค. 64
1 2,319 2,320 2,321 2,322 2,323 3,075